RG
Redmile Group, LLC disclosed a 15% stake in FATE
Redmile Group, LLC reported owning 15% of Fate Therapeutics Inc (FATE) (19,164,572 shares) in a Schedule 13D filed Nov 10, 2026.
A 13D means the holder may push for changes at the company.
Cookies show us what works. Privacy
Cookies show us what works. Privacy
Redmile Group, LLC reported owning 15% of Fate Therapeutics Inc (FATE) (19,164,572 shares) in a Schedule 13D filed Nov 10, 2026.
A 13D means the holder may push for changes at the company.